GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Neptunus Interlong Bio-Technique Co Ltd (HKSE:08329) » Definitions » Retained Earnings

Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Retained Earnings : HK$387 Mil (As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Shenzhen Neptunus Interlong Bio-Technique Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Shenzhen Neptunus Interlong Bio-Technique Co's retained earnings for the quarter that ended in Jun. 2024 was HK$387 Mil.

Shenzhen Neptunus Interlong Bio-Technique Co's quarterly retained earnings increased from Sep. 2023 (HK$0 Mil) to Dec. 2023 (HK$351 Mil) and increased from Dec. 2023 (HK$351 Mil) to Jun. 2024 (HK$387 Mil).

Shenzhen Neptunus Interlong Bio-Technique Co's annual retained earnings increased from Dec. 2021 (HK$0 Mil) to Dec. 2022 (HK$334 Mil) and increased from Dec. 2022 (HK$334 Mil) to Dec. 2023 (HK$351 Mil).


Shenzhen Neptunus Interlong Bio-Technique Co Retained Earnings Historical Data

The historical data trend for Shenzhen Neptunus Interlong Bio-Technique Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Neptunus Interlong Bio-Technique Co Retained Earnings Chart

Shenzhen Neptunus Interlong Bio-Technique Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 333.69 351.34

Shenzhen Neptunus Interlong Bio-Technique Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 359.52 - 351.34 386.61

Shenzhen Neptunus Interlong Bio-Technique Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Shenzhen Neptunus Interlong Bio-Technique Co  (HKSE:08329) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Shenzhen Neptunus Interlong Bio-Technique Co Business Description

Traded in Other Exchanges
N/A
Address
95 Queensway, 18th Floor, United Centre, Admiralty, Hong Kong, HKG
Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing, and selling of medicines and medical devices. It is also involved in the purchase and sales of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are the Manufacturing and selling of medicines; and the Sales and distribution of medicines and healthcare products. The majority of revenue is generated from the Manufacturing and selling of medicines.

Shenzhen Neptunus Interlong Bio-Technique Co Headlines

No Headlines